TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07607470: Large Algorithm Setting and Validation Study

Sponsor: Nanopath, Inc · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 1000 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$9,408,000

Rescue Site Savings

+$6,203,400

Unlock Full NCT07607470 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07607470 Rescue Dossier →